ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)

ClinicalTrials.gov ID: NCT02138747

Public ClinicalTrials.gov record NCT02138747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Double-Blind, Randomized, Two-Period Crossover, Multi-Center Study to Evaluate the Tolerability and Patient Preference Between Myrbetriq® and Detrol® LA in Subjects With Overactive Bladder (OAB)

Study identification

NCT ID
NCT02138747
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Global Development, Inc.
Industry
Enrollment
376 participants

Conditions and interventions

Interventions

  • Mirabegron Drug
  • Tolterodine ER Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 23, 2014
Primary completion
Oct 28, 2015
Completion
Nov 10, 2015
Last update posted
Feb 25, 2020

2014 – 2015

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Site US10002 Urology Centers of Alabama Homewood Alabama 35209
Site US10004 Alaska Clinical Research Center, LLC Anchorage Alaska 99503
Site US10001 Urological Associates of Southern Arizona Tucson Arizona 85715
Site US10003 Genesis Research San Diego California 92123
Site US10010 Skyline Urology Sherman Oaks California 91411
Site US10028 Clinical Research Consulting Milford Connecticut 06460
Site US10024 Coastal Connecticut Research, LLC New London Connecticut 06320
Site US10033 Eastern Research Hialeah Florida 33013
Site US10023 Advanced Clinical Research of Miami Miami Florida 33155
Site US10007 Pinellas Urology, Inc St. Petersburg Florida 33710
Site US10022 Palm Beach Research Center West Palm Beach Florida 33409
Site US10008 The Iowa Clinic PC, Urology West Des Moines Iowa 50266
Site US10014 Mid Atlantic Clinical Research Greenbelt Maryland 20770
Site US10005 Boston Clinical Trials Boston Massachusetts 02131
Site US10021 AccuMed Research Associates Garden City New York 11530-1664
Site US10013 Advanced Urology Centers of New York Plainview New York 11803
Site US10020 Upstate Clinical Research Associates LLC Williamsville New York 14221
Site US10017 The Jackson Clinic Jackson Tennessee 38305
Site US10057 Practice Research Organization Dallas Texas 75230
Site US10035 Millennium Clinical Research Center Arlington Virginia 22203
Site US10032 Clinical Research and Consulting Center, LLC Fairfax Virginia 22030
Site US10034 Health Research of Hampton Roads Inc Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02138747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2020 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02138747 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →